Pharma Strategy: Loss of Exclusivity (LOE) (PowerPoint PPT Slide Deck)

HEALTHCARE PPT DESCRIPTION

Editor Summary Pharma Strategy: Loss of Exclusivity (LOE) is a 25-slide PowerPoint by LearnPPT Consulting that provides a strategic framework and practical templates to manage patent expirations. Read more Covers 3 LOE strategy options (preserve brand equity, develop OTC, launch generics), a 3-phase planning timeline (pre-, peri-, post-LOE), and 5 deliverable templates including a Brand Affinity checklist, LOE planning timeline, strategy development and performance-tracking templates. Sold as a digital download on Flevy with immediate digital download. Used by pharmaceutical executives, marketing, product managers, and business development teams for LOE planning.

Use this deck when a pharmaceutical product is approaching patent expiry and teams must define actions to protect revenue, patient loyalty, and market share.

  Pharmaceutical executives running scenario planning to choose between preserving brand equity, OTC conversion, or generic launch using the Brand Affinity checklist.
  Marketing and sales teams designing patient acquisition and retention programs tied to an LOE timeline and marketing program templates.
  Product managers building a lifecycle execution plan that aligns pre-, peri-, and post-LOE activities with launch milestones.
  Business development leads evaluating market-entry options and regulatory impacts for OTC or generic strategies.

The presentation’s 3-phase timeline and checklist-driven approach reflect structured lifecycle planning used in pharmaceutical strategy engagements.

Read Marcus Overview

Explore Slides inside the Deck:

Strategies for Launching Generic Pharmaceuticals Strategies for Maximizing Brand Value Post-Patent Strategic Timeline for Managing Loss of Exclusivity

Expiration of a drug patent means end of the branded drug value and revenue stream for a majority of pharmaceutical firms. This loss of exclusivity (LOE) puts to risk a huge amount of money in global pharmaceutical sales.

LOE certainly brings about a steep decline in a drug sales. A brand's unit share declines to about 16% by the time generics arrive and play in the market for a year. However, this is not a "game over" scenario.

This deck discusses 3 key strategies to preserve value for the brands after patent expiration:

1. Preserve Brand Equity and Patient Loyalty
2. Develop an Over-the-Counter (OTC) Version
3. Launch a Generic Version

No matter which LOE strategy a company selects to maintain product revenue, early action and execution is critical.

LOE is part of the different phases of a product's lifecycle and should be strategically thought out and managed. The presentation also highlights other avenues to tap revenue opportunities besides extending a drug's patent life through reformulations and introducing new indications.

The slide deck also includes some slide templates for you to use in your own business presentations.

The PPT provides a comprehensive guide on managing the critical phase of Loss of Exclusivity (LOE) in the pharmaceutical industry. It emphasizes the importance of early planning and execution to mitigate the impact on revenue streams. The strategies outlined are not just theoretical, but are backed by practical templates and checklists to facilitate implementation.

The presentation also delves into the nuances of brand affinity and market dynamics, offering insights into how these factors influence the choice of LOE strategy. It includes a detailed timeline for planning and executing LOE strategies, ensuring that companies can navigate this challenging phase with precision and foresight. This resource is indispensable for pharmaceutical executives aiming to sustain brand value and revenue post-patent expiry.

MARCUS OVERVIEW

This synopsis was written by Marcus [?] based on the analysis of the full 25-slide presentation.

Executive Summary
The "Pharma Strategy: Loss of Exclusivity (LOE)" presentation provides a strategic framework for pharmaceutical companies to navigate the critical period surrounding patent expirations. It outlines essential strategies to preserve brand value and revenue streams, focusing on proactive measures that can be taken well before the LOE date. By implementing tactics such as developing over-the-counter (OTC) versions, launching generics, and preserving brand equity, companies can mitigate the financial impact of patent expirations. This presentation is an invaluable resource for executives seeking to maximize product value and maintain competitive positioning in the market.

Who This Is For and When to Use
•  Pharmaceutical executives responsible for brand management and strategy
•  Marketing and sales teams focused on patient acquisition and retention
•  Product managers involved in lifecycle management and LOE planning
•  Business development professionals exploring new market opportunities

Best-fit moments to use this deck:
•  During strategic planning sessions focused on LOE management
•  When developing marketing strategies for products nearing patent expiration
•  In workshops aimed at aligning cross-functional teams on LOE strategies
•  For training sessions on best practices in pharmaceutical brand management

Learning Objectives
•  Define Loss of Exclusivity (LOE) and its implications for pharmaceutical brands
•  Build a comprehensive LOE strategy that includes OTC development and generic launches
•  Establish metrics for measuring brand equity and patient loyalty during LOE
•  Identify key market dynamics that influence LOE strategy effectiveness
•  Create actionable plans for preserving brand value post-patent expiration
•  Develop templates for tracking LOE management initiatives and outcomes

Table of Contents
•  Overview (page 1)
•  Value-extending Strategies (page 6)
•  LOE Management (page 11)
•  LOE Planning and Execution (page 15)
•  Templates (page 19)

Primary Topics Covered
•  Overview of LOE - Discusses the significance of patent expiration and its impact on pharmaceutical sales, emphasizing the need for strategic planning.
•  Value-extending Strategies - Outlines 3 key strategies: preserving brand equity, developing OTC versions, and launching generics to maintain revenue.
•  LOE Management - Introduces the Brand Affinity checklist to guide strategic decision-making and assess customer engagement.
•  LOE Planning and Execution - Details a timeline for effective LOE strategy implementation, highlighting pre-LOE, peri-LOE, and post-LOE phases.
•  Templates - Provides practical templates for organizations to use in their LOE planning and execution efforts.

Deliverables, Templates, and Tools
•  Brand Affinity checklist template for assessing customer engagement
•  LOE planning timeline template to guide execution phases
•  Strategy development templates for OTC and generic product launches
•  Marketing program templates to enhance patient retention and acquisition
•  Performance tracking templates for monitoring LOE strategy effectiveness

Slide Highlights
•  Overview slide detailing the significance of LOE in the pharmaceutical lifecycle
•  Value-extending strategies slide outlining the 3 main tactics for preserving brand value
•  Brand Affinity checklist slide that assists in evaluating customer loyalty and engagement
•  LOE planning timeline slide that breaks down the execution phases into actionable steps
•  Template slides for practical application of strategies discussed in the presentation

Potential Workshop Agenda
LOE Strategy Development Session (90 minutes)
•  Review the implications of LOE on brand value and revenue
•  Discuss the 3 key strategies for managing LOE
•  Break into teams to develop specific action plans for each strategy

Brand Affinity Assessment Workshop (60 minutes)
•  Introduce the Brand Affinity checklist and its importance
•  Analyze current brand performance using the checklist
•  Identify areas for improvement and develop targeted strategies

Customization Guidance
•  Tailor the LOE planning timeline to reflect specific product patent expiration dates
•  Adjust the Brand Affinity checklist to align with specific therapeutic areas and market conditions
•  Incorporate company-specific metrics for tracking the success of LOE strategies
•  Modify templates to fit organizational branding and communication standards

Secondary Topics Covered
•  Market dynamics influencing LOE strategy effectiveness
•  The role of patient education in maintaining brand loyalty
•  Regulatory considerations for developing OTC products
•  Financial implications of launching generics versus preserving branded products

Topic FAQ

What are the typical phases of Loss of Exclusivity planning and what happens in each?

LOE planning is organized into 3 phases: pre-LOE (early strategy development and preparation), peri-LOE (execution around patent expiry and market entry of competitors), and post-LOE (ongoing management of market share and revenue). The deck provides a timeline template that maps activities across these 3 phases.

What strategic options do companies use to mitigate revenue loss at LOE?

Common strategies are preserving brand equity and patient loyalty, developing an over-the-counter (OTC) version, or launching a generic to capture share. The presentation outlines these 3 key approaches and provides templates for OTC and generic strategy development as practical options.

How far in advance should a company start LOE planning to be effective?

The materials recommend beginning LOE planning well before the patent expiry; a specific guideline in the deck is to start at least 2 years prior to anticipated patent expiry to enable execution of chosen strategies and timeline activities.

How can I assess whether my brand has the loyalty to withstand generics entering the market?

Use a Brand Affinity checklist to evaluate customer engagement, loyalty, and comfort with the brand; this assessment informs whether preserving the brand or pivoting to OTC/generic routes is preferable. The deck includes a Brand Affinity checklist template for this assessment.

What should buyers look for when selecting an LOE strategy toolkit for a tight timeline and small team?

Prioritize toolkits that include an LOE planning timeline, ready-made strategy development templates (OTC/generic), marketing program templates, and performance-tracking templates to accelerate execution with limited resources. Pharma Strategy: Loss of Exclusivity (LOE) includes these core templates and tools.

Are pre-built templates useful for LOE planning and how many templates are typically provided?

Pre-built templates streamline planning, ensure consistent tracking, and reduce preparation time for cross-functional workshops. This particular deck supplies 5 practical templates, including the Brand Affinity checklist and performance tracking templates, to support execution.

What market factors should influence the decision between developing an OTC version versus launching a generic?

Key factors include regulatory considerations for OTC conversion, reimbursement dynamics, the number of competing generics expected, and the brand’s current market share—brand unit share often falls substantially once generics enter, with units dropping toward about 16% after one year of generic competition.

How can I structure internal workshops to align teams on LOE strategy quickly?

Use a focused agenda: a 90-minute LOE strategy development session to review implications and draft action plans, and a 60-minute Brand Affinity assessment workshop to apply the checklist, analyze performance, and identify targeted interventions using the deck’s workshop templates.

Document FAQ
These are questions addressed within this presentation.

What is Loss of Exclusivity (LOE)?
LOE refers to the expiration of a drug patent, which typically leads to a significant decline in sales as generic alternatives enter the market.

What strategies can be employed to mitigate the impact of LOE?
Key strategies include preserving brand equity, developing OTC versions, and launching generics to capture market share.

How can companies assess their brand affinity?
Using the Brand Affinity checklist, companies can evaluate customer engagement and comfort with their brand, guiding strategic decisions.

When should companies start planning for LOE?
It is recommended to begin planning at least 2 years prior to the anticipated patent expiry date to ensure effective execution of strategies.

What are the phases of LOE planning and execution?
The LOE planning process is divided into 3 phases: pre-LOE, peri-LOE, and post-LOE, each with specific activities and focus areas.

How can companies track the effectiveness of their LOE strategies?
By utilizing performance tracking templates, companies can monitor key metrics and assess the success of their LOE initiatives.

What is the significance of developing an OTC version?
Creating an OTC version can help maintain and grow volume post-LOE by reaching a broader patient base and addressing reimbursement issues.

What factors influence the decision to launch a generic?
Market dynamics, including the number of competing generics and the brand's current market share, play a critical role in deciding when to launch a generic.

Glossary
•  Loss of Exclusivity (LOE) - The period when a drug patent expires, leading to potential revenue decline.
•  Brand Affinity - The level of customer engagement and loyalty to a brand.
•  Over-the-Counter (OTC) - Products available for purchase without a prescription, often developed to retain market share post-LOE.
•  Generic - A non-branded version of a drug that is typically sold at a lower price.
•  Patient Acquisition - Strategies aimed at attracting new patients to a brand or product.
•  Patient Retention - Efforts to keep existing patients loyal to a brand, especially during LOE.
•  Market Dynamics - The factors that influence the competitive landscape and market behavior.
•  Performance Tracking - The process of monitoring and evaluating the effectiveness of strategies and initiatives.
•  Template - A pre-designed format or framework used to streamline planning and execution processes.
•  Lifecycle Management - The strategic approach to managing a product throughout its lifecycle, from development to LOE.
•  Revenue Stream - The income generated from sales of a product or service.
•  Strategic Planning - The process of defining an organization's direction and making decisions on allocating resources to pursue this direction.

HEALTHCARE PPT SLIDES

Strategies for Launching Generic Pharmaceuticals

This PPT slide outlines a strategic approach for pharmaceutical companies to launch generic products in response to low-cost alternatives. It presents 3 methods: Branded Generic, Authorized Generic, and Licensed Generic. The Branded Generic approach utilizes existing supplies to create a generic version that retains brand identity, appealing to cost-sensitive customers. The Authorized Generic strategy leverages current manufacturing capabilities to produce a private-label version, expanding market reach through partnerships. The Licensed Generic method involves collaborating with competitors to develop a generic product, facilitating earlier market entry, which is critical for capturing market share. Timing is essential, especially when generic competitors have established a presence. The effectiveness of these strategies increases when fewer than 5 generic entrants are in the market.

Strategies for Maximizing Brand Value Post-Patent

This PPT slide outlines 3 strategies for pharmaceutical companies to maximize brand value post-loss of exclusivity (LOE). Proactive planning is essential to capitalize on revenue opportunities after patent expiration. The first strategy focuses on preserving brand equity and patient loyalty through enhanced patient acquisition and retention efforts. The second strategy involves developing an over-the-counter (OTC) version of the drug to slow brand value erosion and capture a different market segment. The third strategy is launching a generic version of the drug, allowing companies to profit from patients who switch to generics. These strategies have been effectively implemented by major pharmaceutical companies like Pfizer and AstraZeneca, providing flexibility in execution.

Strategic Timeline for Managing Loss of Exclusivity

Planning for Loss of Exclusivity (LOE) in the pharmaceutical sector is critical, requiring companies to initiate strategies at least 2 years prior to patent expiry. Delaying action until the LOE date can result in missed opportunities to optimize market position and product value. The LOE planning timeline is divided into 3 phases: Pre-LOE (2 years before LOE, focusing on foundational strategies), Peri-LOE (1 year encompassing the 6 months before and after LOE, emphasizing agile responses), and Post-LOE (1 year after LOE, implementing strategies to sustain brand value and revenue). Meticulous planning is essential for effective strategy execution in navigating patent expirations.

Strategic Approach to Product Lifecycle Management

The "Sunset the Brand" strategy is relevant for firms losing exclusivity in product offerings. It involves a strategic reduction of Stock Keeping Units (SKUs) based on tailored evaluations of expenditures and inventory management while maintaining manufacturing. The timing of the sunsetting process is influenced by market dynamics and the presence of generic competitors, which can accelerate the need for action. Companies must manage their product portfolio effectively, ensuring efficient resource allocation while maintaining market presence. This approach requires a nuanced understanding of internal cost structures and external market conditions, essential for navigating product lifecycle management in a competitive environment. The sunsetting strategy provides a structured pathway to mitigate losses and optimize resource allocation during market transitions.

Strategic Options for LOE Based on Brand Affinity

This PPT slide presents a strategic framework for Loss of Exclusivity (LOE) management in the pharmaceutical sector, focusing on brand affinity. For high brand affinity, preserving brand value and considering over-the-counter (OTC) options is essential. Evaluating FDA approval criteria determines the feasibility of switching to OTC strategies; a positive outcome supports both branded and OTC approaches, while a negative response necessitates reinforcing the branded strategy. Firms lacking exclusivity may struggle with OTC revenue due to diminished market differentiation. For low brand affinity, launching a generic product or sun-setting the brand are viable strategies. A generic launch requires significant resources and speed to market, with securing contracts with distributors and wholesalers being crucial for market share. The decision to pursue an LOE strategy should consider internal capabilities and long-term potential in the generics market.

Source: Best Practices in Pharma Industry PowerPoint Slides: Pharma Strategy: Loss of Exclusivity (LOE) PowerPoint (PPT) Presentation Slide Deck, LearnPPT Consulting